Global Anti-Rheumatics Market Forecast 2020-2028

Publisher Name :
Date: 03-Apr-2020
No. of pages: 168

KEY FINDINGS

The global anti-rheumatics market is anticipated to record a CAGR of 2.32% during the projected period of 2020-2028. The factors that offer lucrative growth opportunities include a surge in the geriatric population all over the world, an increase in the incidences of obesity, a rise in awareness related to early screening and treatment of rheumatoid arthritis.

MARKET INSIGHTS

Rheumatoid arthritis is a chronic inflammatory medical condition, which causes painful and swollen joints in patients. The drugs used for the treatment of rheumatoid arthritis are called anti-rheumatics. In addition, different types of drugs are used to treat this condition. For example, disease-modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs, corticosteroids, and others. A rapid increase in the geriatric population is one of the significant factors driving the market. The global geriatric population has risen considerably and is vulnerable to rheumatoid arthritis.

Patent expirations are one of the factors restricting the market growth. Patent expirations result in the entry of low-priced generics, which constrains its growth. Moreover, the market is flooded with biologics, which are considered important for the treatment of rheumatoid arthritis. Some are on the verge of patent expiration, and some are no longer exclusive. The patent expiration of popular drugs results in the availability of generics, which are low-prices and impact the revenue generated in the market and hinder the market growth. The competitive rivalry is high in the market, owing to the presence of similar products offered by various players. Disease-modifying anti-rheumatics drugs category in the drug class segment garnered the largest market share in 2019.

REGIONAL INSIGHTS

The global anti-rheumatics market is analyzed geographically on the basis of the markets situated across the regions of North America, Europe, Asia Pacific, and the Rest of the World. As of 2019, the region of North America holds the largest market share in terms of revenue. This is attributed to the rising geriatric population.

COMPETITIVE INSIGHTS

The market boasts of many prominent players registering their presence in the global market. Some of the major players functioning in the market are Abbott Laboratories, Lupin Ltd, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Novartis International AG, etc.

Our report offerings include:

- Explore key findings of the overall market

- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

- Market Segmentation cater to a thorough assessment of key segments with their market estimations

- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Global Anti-Rheumatics Market Forecast 2020-2028

Table of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rising Geriatric Population Across The Globe
3.2.2. Increasing Opportunities In The Developing Economies
3.2.3. Surge In The Prevalence Of Rheumatoid Arthritis Disease
3.2.4. Growing Healthcare Expenditure Across The Globe
3.3. Key Restraints
3.3.1. Patent Expirations
3.3.2. Lack Of Regulatory Guidelines For Biosimilars Will Delay Their Availability In Some Regions
3.3.3. Less Expensive Alternatives
4. Key Analytics
4.1. Porter's Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Etiology Of Rheumatoid Arthritis (Ra)
4.3. Symptoms Of Rheumatoid Arthritis
4.4. Risk Factors Associated With Rheumatoid Arthritis
4.5. Opportunity Matrix
4.6. Vendor Landscape
4.7. Key Investment Insights
5. Market By Type
5.1. Prescription-Based Drugs
5.2. Over-The-Counter Drugs
6. Market By Drug Class
6.1. Disease Modifying Anti-Rheumatic Drugs
6.2. Nonsteroidal Anti-Inflammatory Drugs
6.3. Corticosteroids
6.4. Uric Acid Drugs
6.5. Other Drug Class
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
7.2. Europe
7.2.1. The United Kingdom
7.2.2. France
7.2.3. Germany
7.2.4. Italy
7.2.5. Russia
7.2.6. Belgium
7.2.7. Poland
7.2.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Australia & New Zealand
7.3.5. South Korea
7.3.6. Thailand
7.3.7. Indonesia
7.3.8. Vietnam
7.3.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Latin America
7.4.2. Middle East & Africa
8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Amgen Inc
8.4. Becton, Dickinson & Company (Bd)
8.5. Bio-Rad Laboratories Inc
8.6. Bristol-Myers Squibb Company
8.7. Eli Lilly & Company
8.8. Lupin Limited
8.9. F. Hoffmann-La Roche
8.10. Johnson & Johnson
8.11. Merck & Co Inc
8.12. Novartis Ag
8.13. Perkinelmer
8.14. Pfizer Inc
8.15. Ucb

List of Tables

Table 1: Market Snapshot - Anti-Rheumatics
Table 2: Common Symptoms Of Rheumatoid Arthritis
Table 3: Risk Factors For Rheumatoid Arthritis
Table 4: Global Anti-Rheumatics Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 5: Global Anti-Rheumatics Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 6: Global Prescription-Based Drugs Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 7: Global Prescription-Based Drugs Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 8: Global Over-The-Counter Drugs Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 9: Global Over-The-Counter Drugs Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 10: Global Anti-Rheumatics Market, By Drug Class, Historical Years, 2016-2019 (In $ Million)
Table 11: Global Anti-Rheumatics Market, By Drug Class, Forecast Years, 2020-2028 (In $ Million)
Table 12: Global Disease Modifying Anti-Rheumatic Drugs Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 13: Global Disease Modifying Anti-Rheumatic Drugs Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 14: Global Nonsteroidal Anti-Inflammatory Drugs Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 15: Global Nonsteroidal Anti-Inflammatory Drugs Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 16: Global Corticosteroids Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 17: Global Corticosteroids Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 18: Global Uric Acid Drugs Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 19: Global Uric Acid Drugs Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 20: Global Other Drug Class Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 21: Global Other Drug Class Market, By Region, Forecast Years, 2020-2028 (In $ Million)
Table 22: Global Anti-Rheumatics Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 23: Global Anti-Rheumatics Market, By Region Market, Forecast Years, 2020-2028 (In $ Million)
Table 24: North America Anti-Rheumatics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 25: North America Anti-Rheumatics Market, By Country, Forecast Year 2020-2028 (In $ Million)
Table 26: Europe Anti-Rheumatics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 27: Europe Anti-Rheumatics, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 28: Asia Pacific Anti-Rheumatics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 29: Asia Pacific Anti-Rheumatics Market, By Country, Forecast Years, 2020-2028 (In $ Million)
Table 30: Rest Of World Anti-Rheumatics Market, By Region, Historical Years, 2016-2019 (In $ Million)
Table 31: Rest Of World Anti-Rheumatics Market, By Region, Forecast Years, 2020-2028 (In $ Million)

List of Figures

Figure 1: Porter's Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Global Anti-Rheumatics Market, By Type, In 2019
Figure 6: Global Anti-Rheumatics Market, By Prescription-Based Drugs, 2020-2028 (In $ Million)
Figure 7: Global Anti-Rheumatics Market, By Over-The-Counter Drugs, 2020-2028 (In $ Million)
Figure 8: Global Anti-Rheumatics Market, By Drug Class, In 2019
Figure 9: Global Anti-Rheumatics Market, By Disease Modifying Anti-Rheumatic Drugs, 2020-2028 (In $ Million)
Figure 10: Global Anti-Rheumatics Market, By Nonsteroidal Anti-Inflammatory Drugs, 2020-2028 (In $ Million)
Figure 11: Global Anti-Rheumatics Market, By Corticosteroids, 2020-2028 (In $ Million)
Figure 12: Global Anti-Rheumatics Market, By Uric Acid Drugs, 2020-2028 (In $ Million)
Figure 13: Global Anti-Rheumatics Market, By Other Drug Class, 2020-2028 (In $ Million)
Figure 14: North America Anti-Rheumatics Market, Country Outlook, 2019 & 2028 (In %)
Figure 15: The United States Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 16: Canada Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 17: Europe Anti-Rheumatics Market, Country Outlook, 2019 & 2028 (In %)
Figure 18: The United Kingdom Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 19: France Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 20: Germany Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 21: Italy Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 22: Russia Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 23: Belgium Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 24: Poland Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 25: Rest Of Europe Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 26: Asia Pacific Anti-Rheumatics Market, Country Outlook, 2019 & 2028 (In %)
Figure 27: China Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 28: Japan Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 29: India Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 30: Australia & New Zealand Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 31: South Korea Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 32: Thailand Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 33: Indonesia Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 34: Vietnam Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 35: Rest Of Asia Pacific Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 36: Rest Of World Anti-Rheumatics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 37: Latin America Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 38: Middle East & Africa Anti-Rheumatics Market, 2020-2028 (In $ Million)
  • Global Ketogenic Diet Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 139
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Native Bacterial Antigens Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 116
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Insulin Glargine and Lispro Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 132
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Immunosuppressants API Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 131
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Oral Hypoglycemic Drugs Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 164
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Animal Rabies Vaccine Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 138
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Ketogenic Diet Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 138
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Methenamine Hippurate Tablets Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 137
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Agricultural Animal Vaccine Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 165
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs